Cryoablation Allows the Ultimate De-escalation of Surgical Therapy for Select Breast Cancer Patients
A study showing that cryoablation allows the ultimate de-escalation of surgical therapy for select breast cancer patients.
Assessing the Outcome of Cryoablation Treatment on Different Molecular Subtypes of Low-Grade Breast Cancer
Study assessing the outcome of cryoablation treatment on different molecular subtypes of low-grade breast cancer.
Cryoablation of Primary Breast Cancer in Patients Ineligible for Clinical Trials: A Multiinstitutional Study
Study on the cryoablation of primary breast cancer in patients ineligible for clinical trials: a multi-institutional study.
Cryoablation Therapy for Early-Stage Breast Cancer: Evidence and Rationale
This publication provides a comprehensive evaluation of cryoablation as a non-surgical alternative to traditional breast-conserving surgery for early-stage breast cancer.
Percutaneous Ultrasound-Guided Cryoablation for Early-Stage Primary Breast Cancer: A Follow-Up Study in Japan
The study investigates the long-term outcomes of percutaneous cryoablation (PCA) as a minimally invasive treatment for early-stage breast cancer (ESBC).
Feasibility and Safety of Single-Probe Cryoablation with Liquid Nitrogen: An Initial Experience in 24 Various Tumor Lesions
The aim of this retrospective study was to assess the feasibility of the IceCure’s single-probe liquid nitrogen system for tumor lesions of various sizes and locations, and to evaluate the safety of cryoablation with this technique.
Cryoablation Using Liquid Nitrogen for Metastatic Lung Cancers
This retrospective observational study conducted by Professor Hiroaki Nomori, MD found that cryoablation using liquid nitrogen would be one of the treatment methods for metastatic lung cancers <2.2 cm; and pulmonary function decreased significantly when cryoablation was performed for an increasing number of tumors.
Radiation following cryoablation for low risk breast tumors: assessment of safety and variables that effect referral
Poster presented at the 2021 San Antonio Breast Cancer Symposium that examined treatment decisions regarding radiation referral of physicians in the ICE3 trial on cryoablation of small, low-risk breast cancers and evaluated the safety of the combined modalities in this population.
VAB and MRI Following Percutaneous Ultra-Sound Guided Cryoablation for Primary Early-Stage Breast Cancer: A Pilot Study in Japan
This study’s purpose was to evaluate the safety, feasibility, and cosmetic outcomes of cryoablation of breast IDC lesions and evaluate post-cryoablation MRI as a follow up tool for detection of residual malignancies and local recurrences. Study authors concluded that cryoablation of early-stage low-risk breast cancer tumors small than 15cm can be a potential substitute for lumpectomy.
Cryoablation Without Excision for Low-Risk Early-Stage Breast Cancer: 3-Year Interim Analysis of Ipsilateral Breast Tumor Recurrence in the ICE3 Trial
Interim analysis of the ICE3 Clinical Trial on Cryoablation of Small, Low-Risk Breast Cancer as published in the Annals of Surgical Oncology by Dr. Richard E. Fine as the lead author.